Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
04/2002
04/04/2002WO2001090306A3 Compositions and methods for modulating tumor specific expression
04/04/2002WO2001085784A3 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
04/04/2002WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer
04/04/2002WO2001072839A3 Human g-protein coupled receptors
04/04/2002WO2001050848A3 Clonal propagation of primate offspring by embryo splitting
04/04/2002WO2001012777A9 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
04/04/2002US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent
04/04/2002US20020040130 Polymorphic kinase anchor proteins and nucleic acids encoding the same
04/04/2002US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002US20020039572 Infant gene therapy
04/04/2002CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
04/04/2002CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid
04/04/2002CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
04/03/2002EP1192856A2 Caenorhabditis elegans chemosensory bioassay for seven transmembrane receptor ligands
04/03/2002EP1192281A2 Use of ras inhibitors for inhibiting muscle atrophy
04/03/2002EP1192280A1 Synthetic ligation reassembly in directed evolution
04/03/2002EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
04/03/2002EP1192243A1 Method for enhancing hematopoiesis
04/03/2002EP1192183A2 Diagnostic test for thrombotic or thromboembolic disease
04/03/2002EP1192174A2 Antagonists of bmp and tgf beta signalling pathways
04/03/2002EP1191944A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
04/03/2002EP1191938A2 Immunity generation
04/03/2002EP1191841A1 Method of feeding ants and a food dispenser for the purpose
04/03/2002EP1191840A1 Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animals obtained thereby
04/03/2002EP1191839A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
04/03/2002EP0762826B1 Identity and cow estrus indicator
04/03/2002EP0736002B1 Compound capable of introducing at least one molecule into a cell
04/03/2002CN1342403A Automatized maggot raising apparatus
04/03/2002CN1342402A Ecological breeding method of river crab
04/03/2002CN1342401A Gametophyte cloning method of breeding heterotic kelp
04/02/2002US6365797 Prostate cancer cell line; for use in animal models
04/02/2002US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof
04/02/2002US6365365 Method of determining whether an agent modulates glycosyl sulfotransferase-3
04/02/2002US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein
04/02/2002US6364738 Polycarbonate chamber having at least one substantially flat face, and a plurality of open tubes which extend therefrom into the chamber and which are closed at their opposite end.
03/2002
03/28/2002WO2002025270A1 Screening systems and methods for identifying modulators of xenobiotic metabolism
03/28/2002WO2002024940A2 Means for the identification of compounds capable of inhibiting karap-transduced signals
03/28/2002WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe)
03/28/2002WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/28/2002WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024906A1 Induction of exon skipping in eukaryotic cells
03/28/2002WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024891A2 B7-like molecules and uses thereof
03/28/2002WO2002024872A2 Manipulation of spermatozoa
03/28/2002WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/28/2002WO2002024726A2 Olfactory and pheromones g-protein coupled receptors
03/28/2002WO2002023983A2 Method of producing non-human mammals
03/28/2002WO2001094952A3 Methods and compositions for modulating oxidized ldl transport
03/28/2002WO2001091640B1 A method and apparatus for detecting lameness in animals
03/28/2002WO2001088087A3 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
03/28/2002WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof
03/28/2002WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
03/28/2002WO2001038512A3 Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (ptgs)
03/28/2002WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof
03/28/2002US20020038465 Non-human animal mutants and methods for production of the same
03/28/2002US20020038463 Methods for screening and identifying host pathogen defense genes
03/28/2002US20020037852 Anticarcinogenic agents
03/28/2002US20020037556 Heliothis virescens ultraspiracle (USP) protein
03/28/2002US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections
03/28/2002US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals
03/28/2002CA2423111A1 Means for the identification of compounds capable of inhibiting karap-transduced signals
03/28/2002CA2423104A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/28/2002CA2423090A1 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002CA2423044A1 Induction of exon skipping in eukaryotic cells
03/28/2002CA2422921A1 Screening systems and methods for identifying modulators of xenobiotic metabolism
03/28/2002CA2422631A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/28/2002CA2422549A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/28/2002CA2422541A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/28/2002CA2422215A1 B7-like molecules and uses thereof
03/28/2002CA2421865A1 Olfactory and pheromones g-protein coupled receptors
03/27/2002EP1191097A1 Induction of exon skipping in eukaryotic cells
03/27/2002EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2002EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
03/27/2002EP1190079A2 Control of gene expression in eukaryotic cells
03/27/2002EP1190073A2 Control of gene expression
03/27/2002EP1190070A1 Cyclic amp phosphodiesterase isoforms and methods of use
03/27/2002EP1190057A1 Cloning and expression of a novel 5-ht4 receptor
03/27/2002EP1190042A2 Methods for manipulating the avian genome
03/27/2002EP1189629A2 Methods and reagents for treating glucose metabolic disorders
03/27/2002CN1342264A Heart abnormalities in vascular endothelial growth factor B(VEGF-B) deficient animals and methods relating to these heart abnormalities
03/27/2002CN1342165A Neurotrophic growth factor
03/27/2002CN1341352A Hibernation-less quick scorpion-raising method
03/26/2002US6361946 A bone marrow modulating method in mammals by adminstering a polypeptide that binds to at least one endothelial cell surface receptor to modulates myelopoiesis
03/26/2002US6360688 Photoperiodic control of growth
03/21/2002WO2002022886A2 Expression of genes in diabetes mellitus and insulin resistance
03/21/2002WO2002022819A2 Calcium binding proteins
03/21/2002WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
03/21/2002WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
03/21/2002WO2002022789A1 Process for producing normal parenchymal cells, tissue or organ by bioincubator
03/21/2002WO2002022783A2 Liver gene expression associated with the inhibition of hbv replication or transcription
03/21/2002WO2002022776A2 Human coagulation factor vii variants
03/21/2002WO2002022682A1 Interferon-alpha induced gene
03/21/2002WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/21/2002WO2001088115B1 Transgenic caenorhabditis elegans model exhibiting a neuronal dysfunction
03/21/2002WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
03/21/2002WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/21/2002WO2001068859A3 Il-17 receptor like molecules and uses thereof
03/21/2002WO2001064837A3 β NETRIN AND USES THEREOF